Lexington, KY, United States of America

Audra Lynn Stinchcomb

USPTO Granted Patents = 20 

 

 

Average Co-Inventor Count = 3.4

ph-index = 11

Forward Citations = 390(Granted Patents)


Location History:

  • Latham, NY (US) (2003 - 2007)
  • Lexington, KY (US) (2007 - 2017)
  • Baltimore, MD (US) (2017)
  • Ruxton, MD (US) (2017 - 2019)

Company Filing History:


Years Active: 2003-2019

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: Audra Lynn Stinchcomb: Innovator in Transdermal Drug Delivery Systems

Introduction

Audra Lynn Stinchcomb is a distinguished inventor located in Lexington, KY, known for her significant contributions to the field of transdermal drug delivery. With a remarkable total of 20 patents, her innovative work seeks to enhance treatment options for patients, particularly focusing on pain management and abuse deterrence.

Latest Patents

Among her latest patents, Stinchcomb developed an "Abuse deterrent opioid/opioid-antagonist transdermal patch," which features a multilaminate design. This multilaminate includes a first layer containing an opioid analgesic compound and a pressure-sensitive adhesive, complemented by a second layer of an opioid antagonist. Additionally, a barrier layer is strategically placed between the opioid and antagonist layers to enhance protection against misuse.

Another significant patent attributed to her is the "Oxymorphone transdermal patch," which also falls under the realm of pain management. This innovation describes a transdermal patch that utilizes oxymorphone to provide effective pain relief, along with detailed processes for preparing these patches effectively.

Career Highlights

Stinchcomb has showcased her expertise while working with notable organizations, including Alltranz Inc. and the University of Kentucky Research Foundation. Her focus on transdermal systems has cemented her status as a key player in pharmaceutical innovations.

Collaborations

During her career, Stinchcomb has collaborated with esteemed professionals, including Miroslaw Jerzy Golinski and Dana Carmel Hammell. These partnerships have proven to be instrumental in the development and refinement of her inventions, further pushing the boundaries of drug delivery technologies.

Conclusion

Audra Lynn Stinchcomb stands out as an innovative force in the realm of transdermal drug delivery systems. Her extensive patent portfolio, particularly the recent advancements in abuse deterrent technologies, reflects her commitment to improving patient outcomes in medical treatment. As she continues her work, her contributions to the field will undoubtedly make a lasting impact.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…